ask="1.76"
ask_size="2000"
average_daily_volume="1854620"
bid="1.67"
bid_size="300"
book_value="1.98"
change="-0.05"
change_from_200_day_moving_average="-1.87"
change_from_50_day_moving_average="0.08"
change_from_52_week_high="-6.19"
change_From_52_week_low="0.62"
change_in_percent="-2.86%"
close="1.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.08"
ex_dividend_date="N/A"
float_shares="10213000"
high="1.80"
high_52_weeks="7.89"
last_trade_date="3/16/2017"
last_trade_price="1.70"
last_trade_size="9054"
last_trade_time="4:00pm"
low="1.63"
low_52_weeks="1.08"
market_capitalization="31.71M"
moving_average_200_day="3.57"
moving_average_50_day="1.62"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.90"
open="1.75"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-52.40%"
percent_change_from_50_day_moving_average="+5.07%"
percent_change_from_52_week_high="-78.45%"
percent_change_from_52_week_low="+57.41%"
previous_close="1.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.88"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="0.83"
stock_exchange="NGM"
symbol="CATB"
volume="2379807"
weeks_range_52="1.08 - 7.89"
